Daniel Serin

2.6k total citations
45 papers, 1.6k citations indexed

About

Daniel Serin is a scholar working on Oncology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel Serin has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Cancer Research and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel Serin's work include Breast Cancer Treatment Studies (18 papers), Cancer Treatment and Pharmacology (17 papers) and HER2/EGFR in Cancer Research (11 papers). Daniel Serin is often cited by papers focused on Breast Cancer Treatment Studies (18 papers), Cancer Treatment and Pharmacology (17 papers) and HER2/EGFR in Cancer Research (11 papers). Daniel Serin collaborates with scholars based in France, United States and Monaco. Daniel Serin's co-authors include Pierre Kerbrat, Mario Campone, M. Spielmann, T. Delozier, P. Fumoleau, Henri Roché, Alain Monnier, Anne‐Laure Martin, Gilles Romieu and Andrew Kramar and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Daniel Serin

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Serin France 17 1.3k 808 302 242 164 45 1.6k
R. Largillier France 14 940 0.8× 527 0.7× 198 0.7× 334 1.4× 231 1.4× 47 1.5k
Agnès J. van de Wouw Netherlands 21 1.3k 1.1× 554 0.7× 158 0.5× 511 2.1× 273 1.7× 56 1.7k
Diana Lake United States 22 1.2k 1.0× 465 0.6× 289 1.0× 452 1.9× 79 0.5× 70 1.7k
Vieri Scotti Italy 21 764 0.6× 874 1.1× 325 1.1× 516 2.1× 338 2.1× 109 1.6k
Kathleen C. Horst United States 20 597 0.5× 796 1.0× 357 1.2× 272 1.1× 434 2.6× 87 1.6k
P.A. Lawton United Kingdom 12 562 0.4× 817 1.0× 329 1.1× 253 1.0× 321 2.0× 19 1.4k
A. Antón Spain 18 1.3k 1.0× 492 0.6× 179 0.6× 695 2.9× 104 0.6× 103 1.7k
J. Frank Wilson United States 23 519 0.4× 584 0.7× 384 1.3× 404 1.7× 271 1.7× 81 1.6k
Manuel Ramos Spain 16 846 0.7× 688 0.9× 70 0.2× 288 1.2× 313 1.9× 65 1.3k
H.J. Dobbs United Kingdom 12 502 0.4× 861 1.1× 377 1.2× 286 1.2× 337 2.1× 23 1.5k

Countries citing papers authored by Daniel Serin

Since Specialization
Citations

This map shows the geographic impact of Daniel Serin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Serin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Serin more than expected).

Fields of papers citing papers by Daniel Serin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Serin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Serin. The network helps show where Daniel Serin may publish in the future.

Co-authorship network of co-authors of Daniel Serin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Serin. A scholar is included among the top collaborators of Daniel Serin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Serin. Daniel Serin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serin, Daniel, et al.. (2024). La kinésithérapie sénologique : une kinésithérapie spécifique. Kinésithérapie la Revue. 24(276). 28–32.
2.
Pérol, Olivia, Pierre Lebailly, Bénédicte Clin, et al.. (2023). A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients. International Journal of Environmental Research and Public Health. 20(6). 5068–5068. 6 indexed citations
3.
Arnaud, Antoine, et al.. (2016). « SOS SEIN 84 » prise en charge rapide en pathologie mammaire : enquête de satisfaction des consultantes. Bulletin du Cancer. 103(5). 415–420. 1 indexed citations
4.
Cautela, Jennifer, Nathalie Lalevée, Stéphane Éderhy, et al.. (2016). Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives. International Journal of Cardiology. 224. 366–375. 26 indexed citations
5.
Debourdeau, P., Catherine Meuleman, Ghislaine Dufaître, et al.. (2015). Méthodes d’élaboration des recommandations pour la pratique clinique (RPC) et fonctionnement de la plate forme cœur vaisseaux cancer (PTF-CVC) dans l’inter3C Vaucluse pays d’Arles. Bulletin du Cancer. 102(11). 932–939. 2 indexed citations
6.
Pierga, Jean‐Yves, R. Delva, Xavier Pivot, et al.. (2014). Bévacizumab et taxanes dans le traitement de première ligne du cancer du sein métastatique: survie globale et analyse de sous-groupes de l’étude ATHENA France. Bulletin du Cancer. 101(9). 780–788. 3 indexed citations
7.
Arnaud, Antoine, et al.. (2013). Les effets de la radiothérapie sur le système lymphatique. Le mensuel pratique et technique du kinésithérapeute. 544.
8.
Pivot, X., Gilles Romieu, Marc Debled, et al.. (2013). 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial. The Lancet Oncology. 14(8). 741–748. 211 indexed citations
9.
Baffert, Sandrine, Paul Cottu, Youlia Kirova, et al.. (2013). Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study. BMC Health Services Research. 13(1). 456–456. 6 indexed citations
10.
Hardy‐Bessard, Anne‐Claire, R. Delva, Xavier Pivot, et al.. (2012). Tolérance et efficacité du bévacizumab en association aux taxanes en première ligne dans le cancer du sein métastatique : étude ATHENA-France. Bulletin du Cancer. 99(6). 609–618. 8 indexed citations
11.
12.
Romieu, Isabelle, Marina Touillaud, Pietro Ferrari, et al.. (2012). Activité physique et survie après cancer. Bulletin du Cancer. 99(10). 979–994. 8 indexed citations
13.
Extra, Jean-Marc, Anne Vincent‐Salomon, T. Delozier, et al.. (2010). Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study. The Oncologist. 15(8). 799–809. 92 indexed citations
14.
Eisinger, François, L. Cals, Jean‐Yves Blay, et al.. (2008). Impact of organised programs on colorectal cancer screening. BMC Cancer. 8(1). 19 indexed citations
15.
Tolédano, Alain, Marc A. Bollet, Alain Fourquet, et al.. (2007). Does Concurrent Radiochemotherapy Affect Cosmetic Results in the Adjuvant Setting After Breast-Conserving Surgery? Results of the ARCOSEIN Multicenter, Phase III Study: Patients’ and Doctors’ Views. International Journal of Radiation Oncology*Biology*Physics. 68(1). 66–72. 17 indexed citations
16.
Rouëssé, Jacques, Brigitte De La Lande, F. Bertheault-Cvitkovic, et al.. (2006). A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results. International Journal of Radiation Oncology*Biology*Physics. 64(4). 1072–1080. 53 indexed citations
17.
Campone, Mario, P. Fumoleau, Véronique Dièras, et al.. (2006). Gemcitabine and epirubicin in patients with metastatic breast cancer: A phase I/II study. The Breast. 15(5). 601–609. 2 indexed citations
18.
Farsi, Fadila, et al.. (2002). Actualité des réseaux de cancérologie. Bulletin du Cancer. 89(2). 197–206. 2 indexed citations
19.
Sauvan, R, Tetsuro Noguchi, Daniel Serin, et al.. (2001). Three novel BRCA1 germline mutations (1104delAA, 1276delTT, 3747delGA) detected in breast/ovarian cancer families identified in the south of France. Human Mutation. 17(2). 154–154. 2 indexed citations
20.
Eisinger, François, Marc Espié, Christine Lasset, et al.. (1998). La chimioprévention du cancer du sein. Bulletin du Cancer. 85(8). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Largillier Breakdown of academic impact, for papers by Agnès J. van de Wouw Breakdown of academic impact, for papers by Diana Lake Breakdown of academic impact, for papers by Vieri Scotti Breakdown of academic impact, for papers by Kathleen C. Horst Breakdown of academic impact, for papers by P.A. Lawton Breakdown of academic impact, for papers by A. Antón Breakdown of academic impact, for papers by J. Frank Wilson Breakdown of academic impact, for papers by Manuel Ramos Breakdown of academic impact, for papers by H.J. Dobbs
Rankless by CCL
2026